Metro Bank Holdings Plc is a bank holding company, which engages in the provision of banking services through its subsidiary. The company is a deposit-taking and lending institution with a focus on small and medium-sized commercial customers. Its personal banking services include bank accounts, business bank accounts, and insurance. Its business banking services include business accounts, deposit accounts, and borrowing options. Its business accounts include business bank accounts, commercial current accounts, community current accounts, foreign currency accounts and insolvency practitioner accounts. Its deposit account includes business instant access deposit account, business fixed term deposit account, community instant access deposit account, community fixed term deposit account, and others. Its borrowing options include overdrafts, business credit cards, loans, asset finance, and invoice finance. The company serves various sectors such as property, healthcare, charities and not-for-profits, trustee banking, inward investment, and hospitality & leisure.
最新の財務諸表(Form-10K)によると、Metro Bank Holdings PLCの総資産は$16,475で、純利益は$69です。
MTRBFの主要な財務比率は何ですか?
Metro Bank Holdings PLCの流動比率は1.09、純利益率は0、1株当たり売上高は$0です。
Metro Bank Holdings PLCの収益はセグメントまたは地域別にどのように分けられていますか?
Metro Bank Holdings PLC の最大収益セグメントは Genetic Medicines で、最新の利益発表における収益は 290,515,000 です。地域別に見ると、United States が Metro Bank Holdings PLC の主要市場であり、収益は 290,515,000 です。